Network of Young Synbio Investigators: Peter Hildebrandt

Peter Hildebrandt

Peter Hildebrandt is a passionate serial-entrepreneur and CEO of the Center for Commercialization of Synthetic Biology (CC Synbio). His diverse experience includes political consultancy, strategic consultant for governmental organizations, starting and heading successful companies facilitating investor relations and stock trade. Collectively, these experiences and his extensive network has led him to start the venture company PanOpticon Holding, which primarily focuses on IT, biotech and synthetic biology. The venture activities will contribute to the CC Synbio initiative's aim to invest, educate and promote the transition towards a biobased society. CC Synbio's first step is to involve unions, policy makers, researchers, industry and investors in a concerted push towards establishing a biobased production of high value products in Denmark.

Background for The Network of Young Synbio Investigators (NYSI)

PhD students and other junior scientists within the Center for Synthetic Biology are the ones who will carry the knowledge, experience and potential of working in cross-disciplinary collaborations into the future. As such, they are the most important carriers of the cross-disciplinary culture emerging from the convergence of the disciplines represented in the Center.

For this reason, we founded NYSI with the purpose of giving the young scientists of the center an opportunity for gathering in informal surroundings to discuss their projects, socialize and strengthen their identities as participants in cross-disciplinary projects. We also wanted to give the NYSI members access to people who are stakeholders in the world of research, thus strengthening young investigators’ personal networks.